4.7 Article

Workup of Severe Asthma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma

Ioannis Psallidas et al.

Summary: The study showed that although AZD1419 can reduce markers of type 2 inflammation in asthma, it did not improve asthma control; 63% of patients' LOC was predicted by an early rise in FENO; a novel accelerated step-down approach based on FENO may be applicable for patients with well-controlled asthma.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Critical Care Medicine

Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

Liam G. Heaney et al.

Summary: The study compared a biomarker-based treatment adjustment strategy with a symptom-risk-based algorithm in severe asthma patients, finding that the biomarker strategy resulted in a higher proportion of patients reducing corticosteroid dose. Understanding patient non-compliance with treatment advice is an important area for future research. The prevalence of T2 biomarker-low severe asthma was found to be low.

LANCET RESPIRATORY MEDICINE (2021)

Article Critical Care Medicine

Managing Corticosteroid-Related Comorbidities in Severe Asthma

Vidushi Sood et al.

Summary: Oral corticosteroid (OCS) use in severe asthma is still common despite advances in treatment, but monoclonal antibodies have been developed to reduce OCS-treated exacerbations. Strategies for managing endocrine complications associated with OCS use include identifying OCS-dependent patients, optimizing OCS dose, tapering OCS based on asthma control criteria, assessing adrenal axis integrity, and managing corticosteroid-related comorbidities.
Article Medicine, General & Internal

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies-Gow et al.

Summary: Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin, effectively reduces asthma exacerbations in patients with severe, uncontrolled asthma, leading to improved lung function, asthma control, and quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Allergy

Clinical Outcomes in People with Difficult-to-Control Asthma Using Electronic Monitoring to Support Medication Adherence

Claire E. Boddy et al.

Summary: Replacing existing inhaled therapy with fluticasone/salmeterol DINCA for 28 days is acceptable to the majority of people with difficult-to-control asthma and identifies prior medication nonadherence. INCA monitoring coupled with clinical support potentially improves patient adherence and asthma control, preventing unnecessary progression to biological therapy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Letter Critical Care Medicine

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma

Simon Couillard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Respiratory System

Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma

Monica Kraft et al.

Summary: This study identified clinical characteristics and biomarkers associated with elevated exacerbation risk in severe, uncontrolled asthma patients. Factors such as exacerbation history, maintenance corticosteroid use, nasal polyposis, Asian race, geographic region, and elevated blood eosinophil counts and F-ENO concentrations were found to be correlated with increased exacerbation risk when combined or persistently achieving type 2 inflammation criteria.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Critical Care Medicine

Systematic Literature Review of Systemic Corticosteroid Use for Asthma Management

Eugene R. Bleecker et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Respiratory System

Clinical utility of fractional exhaled nitric oxide in severe asthma management

Andrew Menzies-Gow et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Allergy

Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma

Lyndsey M. Muehling et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Respiratory System

Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety

David Price et al.

EUROPEAN RESPIRATORY REVIEW (2020)

Letter Critical Care Medicine

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma

Angela M. Moran et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Review Allergy

Assessment and Management of Occupational Asthma

Paul Cullinan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Editorial Material Respiratory System

Time to FOCUS on oral corticosteroid stewardship in asthma management

Claire N. McBrien et al.

RESPIROLOGY (2019)

Letter Critical Care Medicine

Prognostic and Predictive Value of Blood Eosinophil Count, Fractional Exhaled Nitric Oxide, and Their Combination in Severe Asthma: A Post Hoc Analysis

Rahul Shrimanker et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Critical Care Medicine

Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma

Liam G. Heaney et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Critical Care Medicine

Exacerbation Patterns in Adults with Asthma in England A Population-based Study

Chloe I. Bloom et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Review Respiratory System

Over- and under-diagnosis in asthma

Joanne Kavanagh et al.

BREATHE (2019)

Article Allergy

Oral corticosteroid exposure and adverse effects in asthmatic patients

Patrick W. Sullivan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Article Allergy

Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology

Steven L. Taylor et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Article Medicine, Research & Experimental

Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction

Eleanor M. Dunican et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Medicine, General & Internal

After asthma: redefining airways diseases

Ian D. Pavord et al.

LANCET (2018)

Review Respiratory System

Sleep and asthma

Joanne Kavanagh et al.

CURRENT OPINION IN PULMONARY MEDICINE (2018)

Article Medicine, General & Internal

Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma

Shawn D. Aaron et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Respiratory System

Treatable traits: toward precision medicine of chronic airway diseases

Alvar Agusti et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Allergy

Individualized Household Allergen Intervention Lowers Allergen Level But Not Asthma Medication Use: A Randomized Controlled Trial

Emily DiMango et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)

Review Hematology

How I treat hypereosinophilic syndromes

Amy D. Klion

Article Critical Care Medicine

Dedicated Severe Asthma Services Improve Health-care Use and Quality of Life

David Gibeon et al.

Article Allergy

The prevalence of severe refractory asthma

Pieter-Paul W. Hekking et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Allergy

Diagnosis and management of rhinosinusitis: a practice parameter update

Anju T. Peters et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)

Article Respiratory System

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Article Allergy

Severe asthma: Advances in current management and future therapy

Peter J. Barnes

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Respiratory System

Non-adherence in difficult asthma: time to take it seriously

Liam G. Heaney et al.

THORAX (2012)

Article Critical Care Medicine

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications

Raed A. Dweik et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma

Prescott G. Woodruff et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Allergy

The minimally important difference of the Asthma Control Test

Michael Schatz et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Article Medicine, General & Internal

Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Critical Care Medicine

Cluster analysis and clinical asthma phenotypes

Pranab Haldar et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Biochemistry & Molecular Biology

Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells

Vinod Suresh et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)

Article Critical Care Medicine

Effects of smoking cessation on lung function and airway inflammation in smokers with asthma

Rekha Chaudhuri et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Article Cardiac & Cardiovascular Systems

Measurement properties and interpretation of three shortened versions of the asthma control questionnaire

EF Juniper et al.

RESPIRATORY MEDICINE (2005)

Article Allergy

Development of the asthma control test: A survey for assessing asthma control

RA Nathan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)

Review Medicine, General & Internal

Current concepts: Occupational respiratory diseases.

WS Beckett

NEW ENGLAND JOURNAL OF MEDICINE (2000)